Belatacept in kidney transplant recipients with failed allografts for the prevention of humoral sensitization: A pilot randomized controlled trial

I. Raul Badell, Robert A. Bray, Rivka Elbein, Ashtar S. Chami, Kirk A. Easley, Stephen O. Pastan, Antonio Guasch, Howard M. Gebel, Andrew B. Adams, Christian P. Larsen

Research output: Contribution to journalLetterpeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)E395-E396
Issue number12
StatePublished - Dec 1 2021
Externally publishedYes

Bibliographical note

Funding Information:
The authors would like to acknowledge Bristol-Myers Squibb for funding this investigator-sponsored research trial and supplying belatacept for the study.

Cite this